Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,837 | -41,595 | -34,497 | -30,704 | -22,997 |
| Depreciation Amortization | 860 | 954 | 870 | 660 | 864 |
| Income taxes - deferred | -285 | -133 | -105 | N/A | N/A |
| Accounts receivable | -1,032 | -653 | 280 | -232 | 121 |
| Other Working Capital | -26,089 | 33,520 | 135 | 556 | 1,705 |
| Other Operating Activity | 7,259 | 3,193 | -1,407 | 994 | 740 |
| Operating Cash Flow | $-48,124 | $-4,714 | $-34,724 | $-28,726 | $-19,567 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,187 | -64,969 | -28,480 | 24,609 | -47,563 |
| PPE Investments | -2,637 | -1,240 | -507 | -315 | -279 |
| Investing Cash Flow | $-16,824 | $-66,209 | $-28,987 | $24,294 | $-47,842 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 8,453 | 6,893 | N/A |
| Debt Repayment | -16,743 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 102,538 | 27,518 | 103,138 | 177 | 23,964 |
| Financing Cash Flow | $85,795 | $27,518 | $111,591 | $7,070 | $23,964 |
| Exchange Rate Effect | -593 | 406 | -612 | 753 | 1,889 |
| Beginning Cash Position | 24,755 | 67,754 | 20,486 | 17,095 | 58,651 |
| End Cash Position | 45,009 | 24,755 | 67,754 | 20,486 | 17,095 |
| Net Cash Flow | $20,254 | $-42,999 | $47,268 | $3,391 | $-41,556 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,124 | -4,714 | -34,724 | -28,726 | -19,567 |
| Capital Expenditure | -2,637 | -1,240 | -507 | -315 | -279 |
| Free Cash Flow | -50,761 | -5,954 | -35,231 | -29,041 | -19,846 |